"Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial." by Edward Reiter, MD

Article

Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial.

All Scholarly Works

Edward Reiter, MD, Baystate Health

Document Type

Article, Peer-reviewed

Publication Date

9-1-2004

Abstract

Pubertal gynecomastia is thought to result from transient imbalances between estrogen and androgen concentrations. Anastrozole (ARIMIDEX), a potent and selective aromatase inhibitor, decreases estrogen and increases testosterone concentrations in pubertal

Publication ISSN

0022-4707

Citation Information

J Clin Endocrinol Metab 2004 Sep;89(9):4428-33.